[go: up one dir, main page]

DE60007530D1 - Oral wirksame androgene - Google Patents

Oral wirksame androgene

Info

Publication number
DE60007530D1
DE60007530D1 DE60007530T DE60007530T DE60007530D1 DE 60007530 D1 DE60007530 D1 DE 60007530D1 DE 60007530 T DE60007530 T DE 60007530T DE 60007530 T DE60007530 T DE 60007530T DE 60007530 D1 DE60007530 D1 DE 60007530D1
Authority
DE
Germany
Prior art keywords
androgene
oral effective
oral
effective
effective androgene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60007530T
Other languages
English (en)
Other versions
DE60007530T2 (de
Inventor
Jan Loozen
Dirk Leysen
Der Louw Jaap Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE60007530D1 publication Critical patent/DE60007530D1/de
Publication of DE60007530T2 publication Critical patent/DE60007530T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60007530T 1999-07-16 2000-07-10 Oral wirksame androgene Expired - Fee Related DE60007530T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202348 1999-07-16
EP99202348 1999-07-16
PCT/EP2000/006544 WO2001005806A1 (en) 1999-07-16 2000-07-10 Orally active androgens

Publications (2)

Publication Number Publication Date
DE60007530D1 true DE60007530D1 (de) 2004-02-05
DE60007530T2 DE60007530T2 (de) 2004-12-23

Family

ID=8240463

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60007530T Expired - Fee Related DE60007530T2 (de) 1999-07-16 2000-07-10 Oral wirksame androgene

Country Status (28)

Country Link
US (3) US6313108B1 (de)
EP (1) EP1203011B1 (de)
JP (1) JP2003505394A (de)
KR (1) KR20020092890A (de)
CN (1) CN1360589A (de)
AR (1) AR024746A1 (de)
AT (1) ATE257159T1 (de)
AU (1) AU770412B2 (de)
BR (1) BR0012489A (de)
CA (1) CA2379223A1 (de)
CO (1) CO5200765A1 (de)
CZ (1) CZ2002192A3 (de)
DE (1) DE60007530T2 (de)
ES (1) ES2213596T3 (de)
HK (1) HK1043797A1 (de)
HU (1) HUP0201952A3 (de)
IL (1) IL147332A0 (de)
MX (1) MXPA02000601A (de)
NO (1) NO20020222L (de)
NZ (1) NZ516525A (de)
PE (1) PE20010330A1 (de)
PL (1) PL353007A1 (de)
RU (1) RU2002103883A (de)
SK (1) SK712002A3 (de)
TR (1) TR200200076T2 (de)
TW (1) TW548277B (de)
WO (1) WO2001005806A1 (de)
ZA (1) ZA200200106B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059920A2 (en) * 1999-04-06 2000-10-12 Akzo Nobel N.V. Orally active 7.alpha.-alkyl androgens
WO2003045398A1 (en) * 2001-03-30 2003-06-05 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
WO2001074839A2 (en) * 2000-03-31 2001-10-11 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use
US20030069215A1 (en) * 2001-03-30 2003-04-10 The Government Of The United States Of America, Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate
EP1307471B1 (de) * 2000-07-28 2005-05-04 Akzo Nobel N.V. 16alpha-methyl oder ethyl substituierte oestrogene
CA2472379C (en) * 2002-01-21 2010-05-25 Akzo Nobel N.V. Process for the preparation of 7.alpha.-methylsteroids
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
CN102227441A (zh) * 2008-10-15 2011-10-26 斯索恩有限公司 制备氟维司群的方法和中间体
AU2012264601C1 (en) * 2011-06-01 2018-01-25 Estetra Srl Process for the production of estetrol intermediates
PT2714710T (pt) 2011-06-01 2016-07-12 Estetra Sprl Processo para a produção de intermediários de estetrol
EP2383279A1 (de) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Herstellungsverfahren für Esterol
EP2764008B1 (de) * 2011-10-07 2016-08-17 Estetra S.P.R.L. Verfahren zur herstellung von estetrol
WO2015181116A1 (en) 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids
MD3310346T2 (ro) 2015-06-18 2021-06-30 Estetra Sprl Comprimată orodispersabilă ce conține estetrol
HUE054589T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Szájban diszpergálódó esztetrol tartalmú tabletta
JP6866560B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
MY195019A (en) 2015-06-18 2023-01-03 Estetra Sprl Orodispersible dosage unit containing an estetrol component
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
CN110603059B (zh) * 2017-02-23 2023-06-30 美国西门子医学诊断股份有限公司 化学发光雄烯二酮缀合物
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA712312B (en) * 1970-04-28 1972-01-26 Ochsner Med Found Alton 4,14-estradiene compounds

Also Published As

Publication number Publication date
AU770412B2 (en) 2004-02-19
HUP0201952A3 (en) 2003-10-28
BR0012489A (pt) 2002-04-02
ATE257159T1 (de) 2004-01-15
ZA200200106B (en) 2003-06-25
WO2001005806A1 (en) 2001-01-25
DE60007530T2 (de) 2004-12-23
PL353007A1 (en) 2003-09-22
TW548277B (en) 2003-08-21
CZ2002192A3 (cs) 2002-06-12
EP1203011A1 (de) 2002-05-08
US20020022609A1 (en) 2002-02-21
IL147332A0 (en) 2002-08-14
SK712002A3 (en) 2002-06-04
NO20020222L (no) 2002-01-25
PE20010330A1 (es) 2001-03-22
NZ516525A (en) 2003-06-30
AR024746A1 (es) 2002-10-23
HUP0201952A2 (en) 2002-10-28
US20030087886A1 (en) 2003-05-08
AU6562900A (en) 2001-02-05
TR200200076T2 (tr) 2002-04-22
MXPA02000601A (es) 2002-07-30
CO5200765A1 (es) 2002-09-27
US6313108B1 (en) 2001-11-06
HK1043797A1 (zh) 2002-09-27
US6780854B2 (en) 2004-08-24
RU2002103883A (ru) 2004-02-27
ES2213596T3 (es) 2004-09-01
NO20020222D0 (no) 2002-01-15
CN1360589A (zh) 2002-07-24
EP1203011B1 (de) 2004-01-02
KR20020092890A (ko) 2002-12-12
CA2379223A1 (en) 2001-01-25
US6541465B2 (en) 2003-04-01
JP2003505394A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
DK1308108T3 (da) Tandbörste
ATE261679T1 (de) Zahnbürste
DE60009395D1 (de) Bildanzeige
DE122007000064I2 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
DE60010041D1 (de) Zahnbürste
ATA51899A (de) Handstempel
DE10084428T1 (de) Zahnbürste
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
DE60007530D1 (de) Oral wirksame androgene
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
ATE289496T1 (de) Zahnbürste
DE60013054D1 (de) Reissverschlusszuglasche
DE50006709D1 (de) Zahnbürste
DE50000805D1 (de) Aufsitzspanner
ID30397A (id) Larutan oral prukaloprida
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
ATE440824T1 (de) Nitro-sulfobenzamide
DE10082008D2 (de) Ausbeulgerät
ATE269311T1 (de) Benzoylpyridazine
ATA107599A (de) Heizwasserbereiter
DE10085167T1 (de) Gangumschalteinrichtung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee